This company listing is no longer active
This company may still be operating, however this listing is no longer active. Find out why through their latest events.
Global Blood Therapeutics, Inc. Company Information
Global Blood Therapeutics, Inc.'s employee growth, exchange listings and data sources
Key Information
- Name: Global Blood Therapeutics, Inc.
- Ticker: G5B
- Exchange: DB
- Founded: 2011
- Industry: Biotechnology
- Sector: Pharmaceuticals & Biotech
- Market Cap: US$4.621b
- Listing Market Cap: US$4.688b
- Shares Outstanding: 67.48m
- Website: https://www.gbt.com
Number of Employees
Location
- Global Blood Therapeutics, Inc.
- 181 Oyster Point Boulevard
- South San Francisco
- California
- 94080
- United States
Listings
| Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
|---|---|---|---|---|---|---|
| GBT | NasdaqGS (Nasdaq Global Select) | Yes | Common Stock | US | USD | Aug 2015 |
| G5B | DB (Deutsche Boerse AG) | Yes | Common Stock | DE | EUR | Aug 2015 |
| 0IVZ | LSE (London Stock Exchange) | Yes | Common Stock | GB | USD | Aug 2015 |
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2022/10/05 00:00 |
| End of Day Share Price | 2022/10/04 00:00 |
| Earnings | 2022/06/30 |
| Annual Earnings | 2021/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.